Madrigal Pharmaceuticals Announces Participation at Two Upcoming Virtual Investor Conferences

Madrigal Pharmaceuticals

WEST CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for cardio-metabolic and fatty liver diseases with high unmet medical need such as non-alcoholic steatohepatitis (NASH), announced today its management team will participate in two upcoming virtual investor conferences:

42nd Annual Goldman Sachs Global Healthcare Conference
Fireside chat at 9:40 a.m. ET on Thursday, June 10, 2021

JMP Securities Life Sciences Conference
Fireside chat at 3:30 pm ET on Wednesday, June 16, 2021

The presentation will be webcast live and can be accessed in the Investor Relations section of the Madrigal website and will be available for replay for 90 days.

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Leave a Reply